-
Professor Yujie Wu: Standardized Flow Cytometry Detection of CLL-MRD | The 15th Experimental Diagnostic Hematology Conference of the Chinese Medical Association and the 1st Conference on Rare Blood Diseases
As spring blossoms and nature revives, the 15th Experimental Diagnostic Hematology Conference and the 1st Conference on Rare Blood Diseases, hosted by the Chinese Medical Association, were grandly held in the city of Gusu on March 23-24, 2024. The conference invited renowned experts and scholars from the field of hematology both domestically and internationally to…
-
Dr. Jimmy Che-To LAI, two award winners, talks about the 2024 APASLAnnual Meeting
From March 27 to 31, 2024, the 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2024) was held in Kyoto, Japan. As a top international conference, this year’s APASL annual meeting brings together a large number of the latest research progress. After the feast, the heat did not…
-
Dialogue Interview丨Dr. Jacob George & Dr. Xiaolong Qi discuss frontier hotspots of Metabolic Associated Fatty Liver Disease
The 33rd Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2024) was held in Kyoto, Japan from March 27 to 31, 2024. Metabolic-associated fatty liver disease (MAFLD) was one of the hot topics in the congress. MAFLD has become a common chronic liver disease worldwide and is caused by…
-
Professor Shunqing Wang: Optimizing SAA Hematopoietic Stem Cell Transplantation to Improve Survival and Quality of Life for More Patients | The 19th National Conference on Red Blood Cell Disorders (Anemia) by the Chinese Medical Association
Severe aplastic anemia (SAA) has a sudden onset, severe symptoms, and progresses rapidly. With deepening understanding and continuous breakthroughs in research, hematopoietic stem cell transplantation (HSCT) has been applied in this field, significantly improving clinical efficacy and prognosis for patients. At the recent 19th National Conference on Red Blood Cell Disorders (Anemia) held in China,…
-
Professor Liang Wang:Advances in Ocular Lymphoma Research | Inaugural Academic Forum of the Ocular Lymphoma Collaborative Group
Ocular lymphoma is the most common malignant tumor within the orbit in adults, and its pathological diagnosis and classification are complex, often leading to missed and misdiagnosed cases. Improving the diagnosis rate of ocular lymphoma to better protect patients’ ocular and overall health is a significant challenge for ophthalmologists. On March 30, 2024, the inaugural…
-
Professor Hongyan Tong:Progress in Myelodysplastic Syndromes Research, Current Challenges, and Treatment Strategies | Seventh Beijing Thrombosis and Hemostasis Conference and Fifth Beijing Hematology Oncology and Immunology Summit Forum
From March 2nd to 3rd, 2024, the “Seventh Beijing Thrombosis and Hemostasis Conference and the Fifth Beijing Hematology Oncology and Immunology Summit Forum” was successfully held in Beijing. The event was organized by the National Clinical Research Center for Hematologic Diseases – Peking University Institute of Hematology and the Chinese Academy of Medical Sciences Peking…
-
EBMT China’s Voice | Professor Ruijuan Sun’s Team:Enhancing Pre-Treatment Protocols in allo-HSCT to Effectively Reduce Relapse Rates in High-Risk AML
Editor’s Note: Since 2008, the World Health Organization (WHO) has recognized t(6;9)(p22;q34)/DEK-NUP214 fusion gene-positive acute myeloid leukemia (AML) as a distinct subtype. This type of AML is characterized by a low incidence rate, high malignancy, a high risk of relapse after chemotherapy, and very poor prognosis. Hematopoietic stem cell transplantation can significantly improve these poor…
-
EBMT China Voice | Professor Ruijuan Sun:Comparing the Efficacy and Safety of Post-CD7 CAR-T vs. Post-Chemotherapy CR as a Bridge to Allo-HSCT in Pediatric T-ALL
The 50th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held with great fanfare in Glasgow, UK, from April 14 to 17, 2024. The conference focused on the latest advancements in stem cell transplantation and cellular therapy, pushing forward better clinical outcomes for patients with blood diseases and hematological malignancies.…
Connecting Medical Expertise through Media